Israel’s Thrombotech is shortly to begin trials of its peptide, THR-18, which allows current thrombolytic stroke medication to easily dissolve blood clots, diminishing life-threatening side effects and improving its efficacy.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000714339&fid=1725